Grants and Contributions:

Title:

Market Analysis & Technology Commercialization for the Early Detection of Alzheimer's Disease Using Novel Ophthalmoscope Technologies

Agreement Number:

909046

Agreement Value:

$43,172.00

Agreement Date:

Jun 15, 2018 - Jan 4, 2019

Description:

The proposed project will involve an assessment of industry requirements for the imaging and measurement of molecular and functional bio-markers for Alzheimer's Disease (AD), for the purposes of both early detection of the disease and its effective treatment management. Through detailed market analysis and engagement with early adopters (clinicians and pharmaceutical companies), the three market-segments that have been identified for the firm's proposed technology will be elaborated and their individual use-cases, workflows and requirements established.

Organization:

National Research Council Canada

Expected Results:

The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization

Location:

Vancouver, British Columbia, CA V6B 6H4

Reference Number:

172-2018-2019-Q1-909046

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

784721888

Recipient Type:

For-profit organization

Additional Information:

This agreement has been amended 1 time(s). The end date of this agreements has been modified by 20 days.

Amendment Date

Oct 30, 2018

Recipient's Legal Name:

Photonic Signatures Inc.

Federal Riding Name:

Vancouver Centre

Federal Riding Number:

59034

Program:

Industrial Research Assistance Program – Contributions to Firms

Program Purpose:

Coverage:

IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.

NAICS Code:

334512

Amendments:

See Amendments